Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells.
about
P1343
PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2Structure of two forms of the interferon-induced (2'-5') oligo A synthetase of human cells based on cDNAs and gene sequencesGamma-actin: unusual mRNA 3'-untranslated sequence conservation and amino acid substitutions that may be cancer relatedIGRhCellID: integrated genomic resources of human cell lines for identificationThe first 30 years of p53: growing ever more complexSulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells3,6-Epidioxy-1,10-bisaboladiene inhibits G1 -specific transcription through Swi4/Swi6 and Mbp1/Swi6 via the Hog1 stress pathway in yeast.Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration scheduleThymidylate synthase protein and p53 mRNA form an in vivo ribonucleoprotein complexA new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate.Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells.Topoisomerase IIalpha binding domains of adenomatous polyposis coli influence cell cycle progression and aneuploidy.Mechanisms of p53 loss in human sarcomas.Proteasome- and p38-dependent regulation of ERK3 expression.The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia.Genomic instability in head and neck cancer patients.p53 Research: the past thirty years and the next thirty years.Cytotoxic effects of tetracycline analogues (doxycycline, minocycline and COL-3) in acute myeloid leukemia HL-60 cellsp53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome.A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors.CDK inhibitors in clinical development for the treatment of cancer.New small molecules, ISA27 and SM13, inhibit tumour growth inducing mitochondrial effects of p53Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cellsIncreased expression of p53 protein in human leukemia cells.Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine.MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapySulfonoquinovosyl diacylglyceride selectively targets acute lymphoblastic leukemia cells and exerts potent anti-leukemic effects in vivo.Modulation of vinblastine cytotoxicity by dilantin (phenytoin) or the protein phosphatase inhibitor okadaic acid involves the potentiation of anti-mitotic effects and induction of apoptosis in human tumour cells.A limited role of p53 on the ability of a Hexane fraction of American ginseng to suppress mouse colitis.The HL60 cell line: a model system for studying human myeloid cell differentiation.Expression of the p53 oncogene in acute myeloblastic leukemia.EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.Human DMTF1β antagonizes DMTF1α regulation of the p14(ARF) tumor suppressor and promotes cellular proliferation.Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia.Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1.Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status.Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell linesp53-Independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA.Erk5 contributes to maintaining the balance of cellular nucleotide levels and erythropoiesis.
P2860
Q24313485-446A26C0-9523-4FC6-A9BD-B6E81604FA4DQ24555798-C4FBA3C1-8C8D-4128-98B5-8F65AD155C1AQ24612134-57062A22-65B2-4B2B-9334-37ED3D34EBC6Q24614535-5EC29837-0050-4781-8076-D8207C015530Q24645732-7D3A974E-DA0F-4893-8021-246DBBD2731BQ24683705-9DE055C2-8C62-46DA-AFEA-0B0CA7B0F7B4Q27937305-B08D5F84-2F52-4DCB-AD46-5C46487A1ACEQ28371265-C492ABCB-0325-4462-BE89-2CF83288A107Q28584078-08E8D5A9-FE80-49A5-8D77-94581E97B9D2Q32160704-9CEE3AFC-A032-4BD3-82EB-CC0C0CE8DA6BQ33200966-1E44BD2E-E998-4BB8-A222-7F0B193516E8Q33549689-38DCA9F8-670D-4182-8370-FF13902D0196Q33722859-E2D3D693-ABF1-4A8C-915B-01A1BF9F0509Q33930614-1AC1F20D-F936-4D0F-9223-064BB5F95751Q34264856-4FFBB9CA-1EAF-4AA7-A750-C0006E1C5729Q34302293-D8D4A3FB-63F1-4EED-ABB7-B86B3B6D096AQ34313764-F8AEF4AA-E7F6-43A5-A304-8C8EC3DFB8B7Q34703798-8663BE7D-AE8C-46B3-8257-A8699DCE407FQ35103179-09096BA4-67FE-4595-8713-67F7CF021DE3Q35134137-2D766334-2C0B-456F-BE97-8D19465B074BQ35143997-29F6FA5F-9878-4F77-8C18-4F3B1747E63EQ35448347-3338D845-27C1-487D-B56F-30EEEBC934BCQ35552294-F0A1C37B-6FFB-4558-8368-2683EE0FEB38Q35609543-35E6DBDD-5740-4C20-A2F4-C8C71DB4B3E7Q35847836-E7A4DE5B-9D78-4B01-92D0-2D4A1606F895Q35848425-93B4B29E-250A-446B-A6DC-9F110021FF0BQ35865482-855B033B-15F0-4C94-BED8-DB6213860B72Q36134474-79D0DBF3-13E4-47CB-82C3-E31F2909E1F6Q36148554-E717A962-583D-4B9C-86BB-C43E3F0A42B7Q36290227-C91E029C-31EF-4261-B598-135EC550E082Q36352855-D87FC4C5-0CE0-4485-901E-8220D7EA4B17Q36358319-DBAB2F10-DDC9-45E4-8340-5C37E1A3E729Q36394792-4B81BB80-D13E-46FC-B9FC-2F0841AE6607Q36515569-A0F3A84C-E298-4A82-884B-365DAA19BB02Q36636879-67FA1BA3-29B9-46FF-B177-E8C4263E5056Q36665942-176FC27A-E062-41A0-9517-03D502A6188EQ36678903-25DBD330-E0F2-4A02-B244-09E9EB95BD99Q36729673-E3B231F3-AF69-42FF-90B8-165C46700CDFQ36738027-2058B2E0-0934-4419-BDDB-8FE4CC3C4493Q36781128-7AD0FEDE-3DBE-4447-B6CA-664EE777FC7C
P2860
Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1985
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Major deletions in the gene en ...... p53 expression in HL-60 cells.
@en
Major deletions in the gene en ...... p53 expression in HL-60 cells.
@nl
type
label
Major deletions in the gene en ...... p53 expression in HL-60 cells.
@en
Major deletions in the gene en ...... p53 expression in HL-60 cells.
@nl
prefLabel
Major deletions in the gene en ...... p53 expression in HL-60 cells.
@en
Major deletions in the gene en ...... p53 expression in HL-60 cells.
@nl
P2860
P356
P1476
Major deletions in the gene en ...... p53 expression in HL-60 cells.
@en
P2860
P304
P356
10.1073/PNAS.82.3.790
P407
P577
1985-02-01T00:00:00Z